Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Major Depressive Disorder | Treatment Algorithms: Claims Data Analysis | US | 2023
Major depressive disorder (MDD) is a highly drug-treated condition that uses an array of drug classes, including, but not limited to, selective serotonin reuptake inhibitors (SSRIs), selective…
Unipolar Depression | Disease Landscape & Forecast | Major Depressive Disorder | G7 | 2022
The unipolar depression therapy market is crowded and highly genericized. The prominent use of drugs such as selective serotonin reuptake inhibitors (SSRIs) as early-line treatments contributes to…
Major Depressive Disorder | Treatment Algorithms: Claims Data Analysis | US | 2022
Major depressive disorder (MDD) is a highly drug-treated condition that utilizes an array of drug classes, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine…
Major Depressive Disorder | Treatment Algorithms | Claims Data Analysis | US | 2021
Treatment for major depressive disorder (MDD) involves a range of safe and effective therapies, many of which are available as inexpensive generics. Agents for treating MDD span multiple drug…
